# Directed Ablation of Uterine Fibroids Using a Noninvasive Approach

> **NCT03219385** · NA · UNKNOWN · sponsor: **Mirabilis Medica, Inc.** · enrollment: 180 (estimated)

## Conditions studied

- Uterine Leiomyoma

## Interventions

- **DEVICE:** Mirabilis System

## Key facts

- **NCT ID:** NCT03219385
- **Lead sponsor:** Mirabilis Medica, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09
- **Primary completion:** 2020-09
- **Final completion:** 2022-09
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2018-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03219385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03219385, "Directed Ablation of Uterine Fibroids Using a Noninvasive Approach". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03219385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*